Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scores

Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline: Global Strategy for the Diagnosis, management and Prevention of Chronic Obstructive Pulmonary Disease (updated 2009). last accessed 12 May 2011, [ http://www.goldcopd.com ]

Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF, American Thoracic Society; European Respiratory Society Task Force on outcomes of COPD: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008, 31: 416-469. 10.1183/09031936.00099306.

Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42: 773-778. 10.1136/thx.42.10.773.

van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003, 1: 13-10.1186/1477-7525-1-13. 28

Jones PW, Quirk FH, Baveystock CM: The St George's Respiratory Questionnaire. Respir Med. 1991, 85 (Suppl B): 25-31.

Meguro M, Barley EA, Spencer S, Jones PW: Development and validation of an improved COPD-specific version of the St George's Respiratory Questionnaire. Chest. 2006, 132: 456-463.

Jones PW: St. George's Respiratory Questionnaire: MCID. COPD. 2005, 2: 75-79. 10.1081/COPD-200050513.

Jones PW: Interpreting thresholds for a clinically significant changes in health status in asthma and COPD. Eur Respir J. 2002, 19: 398-404. 10.1183/09031936.02.00063702.

Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.

Jones P, Harding G, Wiklund I, Berry P, Leidy N: Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009, 18: 208-215. 10.4104/pcrj.2009.00053.

Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.

Rasch G: Probabilistic models for some intelligence and attainment tests. AA. 1960, Chicago: University of Chicago Press

Barley EA, Jones PW: Repeatability of a Rasch model of the AQ20 over five assessments. Qual Life Res. 2006, 15: 801-809. 10.1007/s11136-005-5466-z.

Andrich D, Sheridon BE, Luo G: RUMM2020 (Rasch unidimensional measurement models). AA. 2005, Perth: RUMM Laboratory

Hawthorne G, Densley K, Pallant JF, Mortimer D, Segal L: Deriving utility scores from the SF-36 health instrument using Rasch analysis. Qual Life Res. 2008, 17: 1183-1193. 10.1007/s11136-008-9395-5.

Young TA, Rowen D, Norquist J, Brazier JE: Developing preference-based health measures: using Rasch analysis to generate health state values. Qual Life Res. 2010, 19: 907-917. 10.1007/s11136-010-9646-0.

Wright BD, Linacre JM: Glossary of Rasch Measurement Terminology Rasch Measurement Transactions. 2001, 15: 824-825. last accessed 12 May 2011, [ http://www.rasch.org/rmt/rmt152e.htm ]